Samir Jain, MD
Internal Medicine · Toms River, NJNPI 1851312656
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $19,700 of the $32,235 with a category attached, or 61.1%. Edwards Lifesciences accounts for 86.9% of it on its own, with 31 other manufacturers making up the rest. 2025 is the largest year on record at $20,389, more than ten times the $287 reported in 2019. Among internal medicine clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 241 payments — averaging $133.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Edwards Lifesciences$28K
- AstraZeneca$586
- Novartis$495
- Boehringer Ingelheim$321
- Spinal Simplicity, LLC$292
- Pfizer$288
- plus $2K from 26 others
What the payments were for
- Consulting fees$19,70061%
- Travel & lodging$7,62524%
- Food & beverage$4,91015%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Edwards Lifesciences | 25 | $28,013 |
| AstraZeneca | 17 | $586 |
| Novartis | 48 | $495 |
| Boehringer Ingelheim | 20 | $321 |
| Spinal Simplicity, LLC | 2 | $292 |
| Pfizer | 19 | $288 |
| Novo Nordisk | 18 | $280 |
| Abbott | 8 | $257 |
| E.r. Squibb & Sons, L.L.C. | 17 | $240 |
| Amgen | 14 | $214 |
| Boston Scientific | 4 | $199 |
| Johnson & Johnson | 12 | $179 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 8 | $153 |
| Abiomed | 1 | $144 |
| Cvrx, Inc. | 5 | $80 |
| Bard Peripheral Vascular, Inc. | 1 | $79 |
| Baxter Healthcare | 3 | $70 |
| Scpharmaceuticals Inc. | 3 | $69 |
| Philips North America LLC | 2 | $31 |
| Terumo Medical Corporation | 2 | $27 |
| Vital Connect, Inc | 1 | $26 |
| Silk Road Medical, Inc. | 1 | $26 |
| Heartflow, Inc. | 1 | $25 |
| Impulse Dynamics (USA) Inc. | 1 | $19 |
| Alnylam Pharmaceuticals Inc. | 1 | $18 |
| Esperion Therapeutics, Inc. | 1 | $17 |
| Kestra Medical Technology Services, Inc. | 1 | $16 |
| Aurinia Pharma U.S., Inc. | 1 | $15 |
| Sanofi-aventis U.S. LLC | 1 | $15 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
| Gilead | 1 | $14 |
| Medicure Pharma Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Edwards SAPIEN 3 Transcatheter Heart Valve$19,700
- FARXIGA$341
- Minuteman$225
- PASCAL$190
- SAPIEN 3 Ultra RESILIA$168
- Impella$144
- WATCHMAN Access System$132
How this compares
$32,235 in reported general payments places this provider in the 95th percentile of 4,032 internal medicine providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 157 | $193,074 |
| FarxigaDapagliflozin Propanediol | 80 | $101,262 |
| EliquisApixaban | 61 | $80,300 |
| Repatha SureclickEvolocumab | 44 | $49,322 |
| OzempicSemaglutide | 23 | $28,948 |
| EntrestoSacubitril/Valsartan | 15 | $26,882 |
| MultaqDronedarone Hcl | 13 | $22,150 |
| Metoprolol Succinate | 661 | $11,020 |
| BrilintaTicagrelor | 13 | $10,919 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 150 | $5,311 |
| Rosuvastatin Calcium | 283 | $4,890 |
| Valsartan | 132 | $3,778 |
| Atorvastatin Calcium | 331 | $3,538 |
| Nebivolol Hcl | 56 | $2,922 |
| Nifedipine ErNifedipine | 78 | $2,497 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $321 | $193,074157 claims |
| AstraZenecaFarxiga, Brilinta | $586 | $112,18193 claims |
| PfizerEliquis | $288 | $80,30061 claims |
| Novo NordiskOzempic | $280 | $28,94823 claims |
| NovartisEntresto | $495 | $26,88215 claims |
| Sanofi-aventis U.S. LLCMultaq | $15 | $22,15013 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,032 internal medicine providers in New Jersey.
Other internal medicine in Toms River
- Akshay PatelToms River$27K
- Ralph GuarinoToms River$26K
- David ShulkinMorristown$1.7M
- Howard UdermanLakewood$955K
- Darshi SunderamEast Orange$530K
- Annika DrongeEmerson$401K
- Stephen MarcellaNew Brunswick$331K
- Viju VijaysadanKinnelon$325K
- Mark MonaneWoodcliff Lake$268K
- Martin BedigianLivingston$240K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.